These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1755 related items for PubMed ID: 17593332

  • 1. Young age influences treatment but not outcome of colon cancer.
    Quah HM, Joseph R, Schrag D, Shia J, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [Abstract] [Full Text] [Related]

  • 2. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
    Tsikitis VL, Larson DL, Wolff BG, Kennedy G, Diehl N, Qin R, Dozois EJ, Cima RR.
    J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
    [Abstract] [Full Text] [Related]

  • 3. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.
    Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG.
    J Clin Oncol; 2005 Dec 01; 23(34):8706-12. PubMed ID: 16314630
    [Abstract] [Full Text] [Related]

  • 4. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
    Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG.
    J Clin Oncol; 2003 Aug 01; 21(15):2912-9. PubMed ID: 12885809
    [Abstract] [Full Text] [Related]

  • 5. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.
    Dis Colon Rectum; 2008 May 01; 51(5):503-7. PubMed ID: 18322753
    [Abstract] [Full Text] [Related]

  • 6. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J, Kulaylat M, Rockette H, Hassett J, Rajput A, Dunn KB, Dayton M.
    Ann Surg; 2009 Apr 01; 249(4):559-63. PubMed ID: 19300237
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.
    Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, Kim C.
    Ann Surg Oncol; 2007 May 01; 14(5):1712-7. PubMed ID: 17253102
    [Abstract] [Full Text] [Related]

  • 8. The clinicopathological characteristics and outcome of patients with right colon cancer.
    Tomoda H, Taketomi A, Baba H, Kohnoe S, Seo Y, Saito T.
    Oncol Rep; 1998 May 01; 5(2):481-3. PubMed ID: 9468584
    [Abstract] [Full Text] [Related]

  • 9. A critical appraisal of treatment for T3N0 colon cancer.
    Yo IS, Opelka FG, Bolton JS, Fuhrman GM.
    Am Surg; 2001 Feb 01; 67(2):143-8. PubMed ID: 11243538
    [Abstract] [Full Text] [Related]

  • 10. Adequacy and importance of lymph node evaluation for colon cancer in the elderly.
    Bilimoria KY, Stewart AK, Palis BE, Bentrem DJ, Talamonti MS, Ko CY.
    J Am Coll Surg; 2008 Feb 01; 206(2):247-54. PubMed ID: 18222376
    [Abstract] [Full Text] [Related]

  • 11. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV, Kim RJ, Small W, Rademaker AW, Helenowski IB, Singh DK, Schink JC, Lurain JR.
    Gynecol Oncol; 2009 Aug 01; 114(2):273-8. PubMed ID: 19428094
    [Abstract] [Full Text] [Related]

  • 12. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D, Bonadeo FA.
    Dis Colon Rectum; 2009 Jul 01; 52(7):1244-50. PubMed ID: 19571700
    [Abstract] [Full Text] [Related]

  • 13. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.
    Vather R, Sammour T, Kahokehr A, Connolly AB, Hill AG.
    Ann Surg Oncol; 2009 Mar 01; 16(3):585-93. PubMed ID: 19116751
    [Abstract] [Full Text] [Related]

  • 14. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):796-802. PubMed ID: 19289261
    [Abstract] [Full Text] [Related]

  • 15. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
    O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, André T, Haller DG, Sargent DJ.
    J Clin Oncol; 2008 May 10; 26(14):2336-41. PubMed ID: 18467725
    [Abstract] [Full Text] [Related]

  • 16. Disparities in the treatment of colon cancer in octogenarians.
    Hardiman KM, Cone M, Sheppard BC, Herzig DO.
    Am J Surg; 2009 May 10; 197(5):624-8. PubMed ID: 19393356
    [Abstract] [Full Text] [Related]

  • 17. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
    Bowne WB, Lee B, Wong WD, Ben-Porat L, Shia J, Cohen AM, Enker WE, Guillem JG, Paty PB, Weiser MR.
    Dis Colon Rectum; 2005 May 10; 48(5):897-909. PubMed ID: 15785892
    [Abstract] [Full Text] [Related]

  • 18. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
    Martenson JA, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL, Thomas CR, Fisher B, Benson AB, Myerson R, Goldberg RM.
    J Clin Oncol; 2004 Aug 15; 22(16):3277-83. PubMed ID: 15249584
    [Abstract] [Full Text] [Related]

  • 19. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
    Bilchik AJ, DiNome M, Saha S, Turner RR, Wiese D, McCarter M, Hoon DS, Morton DL.
    Arch Surg; 2006 Jun 15; 141(6):527-33; discussion 533-4. PubMed ID: 16785352
    [Abstract] [Full Text] [Related]

  • 20. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM.
    J Clin Oncol; 2004 May 15; 22(10):1797-806. PubMed ID: 15067028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 88.